We have previously shown that ablation of either the Phospho1 or Alpl gene, encoding PHOSPHO1 and tissue-nonspecific alkaline phosphatase (TNAP) respectively, lead to hyperosteoidosis but that their chondrocyte-and osteoblast-derived matrix vesicles (MVs) are able to initiate mineralization. In contrast, the double ablation of Phospho1 and Alpl completely abolishes initiation and progression of skeletal mineralization. We argued that MVs initiate mineralization by a dual mechanism: PHOSPHO1-mediated intravesicular generation of P i and phosphate transporter-mediated influx of P i generated perivesicularly. To test this hypothesis, we generated mice with the col2a1-driven cremediated ablation of P i t1 alone or in combination with a Phospho1 gene deletion. These data proves the involvement of PiT-1 function in the initiation of skeletal mineralization and it provides compelling evidence that PHOSPHO1 mediates MV biogenesis.
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P i t1
col2/col2 mice did not show any major phenotypic abnormalities, while severe skeletal deformities were observed in the [Phospho1 col2/col2 MVs. We also found a significant decrease in the
INTRODUCTION
Mineralization of cartilage and bone occurs by a series of physicochemical and biochemical processes that together facilitate the deposition of hydroxyapatite in specific areas of the extracellular matrix (ECM). Tissue-nonspecific alkaline phosphatase (TNAP) plays a crucial role in restricting the concentration of the mineralization inhibitor inorganic pyrophosphate (PP i ) to maintain a P i /PP i ratio permissive for normal propagation of mineral in the extracellular matrix (Moss et al., 1967; Majeska et al., 1975; Johnson et al., 2000; Hessle et al., 2002; Murshed et al., 2005; Yadav et al., 2011; Millán, 2012; McKee et al., 2013) . Alpl -/-mice chondrocyte and osteoblast-derived matrix vesicles (MVs) however are still able to initiate mineralization (Anderson et al., 1997 (Anderson et al., , 2004 , indicating that other enzymes or mechanisms are involved in the intravesicular initiation of mineralization. Subsequently, we showed that PHOSPHO1, an enzyme that uses phosphocholine and phosphoethanolamine to concentrate P i inside MVs, is also required for proper bone mineralization (Roberts et al., 2007; Huesa et al., 2011; Yadav et al., 2011; McKee et al., 2013) , as the lack of PHOSPHO1 (Phospho1 -/-mice) also leads to skeletal and dental hypomineralization. Importantly, the [Alpl
double knockout mice are embryonic lethal and the E16.5 embryos show complete absence of skeletal mineralization and MVs devoid of mineral . We hypothesized that MV-mediated initiation of mineralization results from a dual mechanism, i.e. PHOSPHO1-mediated intra-vesicular production and transportermediated influx of P i . Two related type III Na/Pi co-transporters, P i T-1/Glvr1 and P i T-2/Ram, are both expressed by chondrocytes and osteoblasts, but literature reports that
PiT-1 is the major mediator of P i influx in these cell types (Nielsen et al., 2001; Yoshiko et al., 2007; Polewski et al., 2010) . Thus, to test this hypothesis we generated mice with a conditional ablation of P i T-1 gene (Slc20a1, here referred to as Pit1) alone or in the
Phospho1
-/-background. Our data proves the involvement of P i T-1 function in the initiation of endochondral ossification and also points to PHOSPHO1 as an enzyme controlling MV biogenesis.
MATERIALS AND METHODS

Mice
Phospho1-R74X null mutant (Phospho1 -/-) mice were generated as described . The generation and characterization of the P i t1 flox/flox mice was reported earlier (Beck et al., 2010 
TTAGCCTGGATAGAGCAACCGC-3'.
Tissue and plasma collection and histological studies
Mice were anesthetized by intraperitoneal injection of Avertin and blood was collected by cardiac puncture. Whole-body, long bones and spine radiographic images were taken using an MX20 Specimen Radiograph System (Faxitron X-ray Corporation, Chicago, IL, USA) at 1 month of age. The lumbar spines, tibias, and femurs of 15-days-old mice were fixed in PBS containing 4% (vol/vol) paraformaldehyde. Paraffin or plastic sections were stained with Von Kossa/Van Gieson stain using standard procedures (Murshed et al., 2005; Millan et al., 2008 and Narisawa et al., 2001) . Von Kossa/Van Gieson-stained slides were used for quantification of osteoid volume using the Bioquant Osteo Software (Bioquant Osteoanalysis Co., Nashville, TN, USA.
For P i T-1 immunohistochemistry, bone tissues were decalcified with 0.125 M EDTA/10% formalin in H 2 O (pH 7.2) for five days after fixation, and processed for paraffin sectioning. Immunostaining was performed using a standard avidin-biotin complex protocol using the Vectastatin ABC kit (Vector laboratories Inc, Burlingame, CA). Rabbit anti-mouse OPN antibody (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) was used for detection of P i T-1.
P i t1 gene expression
Primary chondrocytes from WT and P i t1 col2/col2 mice were isolated from the knee joint growth plates of 5 day-old pups by collagenase digestion, as described previously . RNA was extracted using RNAeasy Pus Kit (Qiagen, Valencia, CA, USA).
Specific RNA transcript (mRNA) for Pit1 was quantified by real-time PCR using duallabeled hydrolysis probes (FAM-TAMRA). P i t1 primers and probe sequences are as follows:
CACATCTATCAAGCCGTTCC3' and FAM-TAMRA Probe-5'CGAAACTGTGGGCTCCGCC3'.
Biochemical assays
Blood was collected by cardiac puncture into lithium heparin tubes and plasma was collected by centrifugation at 5000 rpm for 10min. Alkaline phosphatase activity in plasma was measured using a previously reported method (Millán et al., 2008) . PP i levels were measured using activated charcoal and 3 H method as we previously reported (Mcguire et al., 1980; Yadav et al, 2011) . Calcium levels were measured using the cresolphthalein complexone liquicolor test kit (Stanbio, Boerne, Tx, USA) according to the manufacturer's protocol.
Micro-computed tomography (µCT)
Mice were euthanized at 1 month of age, the tibias and femurs dissected and fixed in 4%
paraformaldehyde. Samples were imaged on a µCT scanner (Skyscan 1076, Kontich, Belgium). Samples were wrapped in tissue paper that was moistened with phosphate buffered saline (PBS), and scanned at 9µm voxel size, applying an electrical potential of 50 kVp and current of 200uA, using a 0.5mm aluminum filter. Mineral density was determined by calibration of images against 2mm diameter hydroxyapatite (HA) rods (0.25 and 0.75 gHA/cm3). Additionally, a beam hardening correction algorithm was applied prior to image reconstruction.
To visualize and determine bone histomorphometric parameters, the software, Dataviewer, CTAn, CTVol and CTVox (all Skyscan, Kontich, Belgium) was used.
Cortical bone analysis was performed on the femur and tibia midshafts. The volumes of interest were selected in reference to an identified landmark1. Since all animals were 1 month of age, the volumes of interest were (1) 3600-4500 µm proximal to the distal femur growth plate and (2) 3600-4500 µm distal to the tibia proximal growth plate. The cortical bone in this region was selected by automatic contouring of the periosteal tissue excluding the marrow cavity. A global threshold was used to identify cortical bone and an erosion of one pixel was performed to eliminate partial volume effects. From these regions of femoral and tibial cortical bone, the following parameters were determined: using Skyscan CTAn and the 3 dimensional (3D) models visualized in CTvol software .
3-point bending for the determination of bone stiffness and breaking strength
An Instron 3342 materials testing machine (Instron, Norwood, MA, USA) fitted with a 2 kN load cell was used to determine bone stiffness and breaking strength (Aspden, 2003) .
The span was fixed at 5.12 mm for femurs. The cross-head was lowered at 1 mm/min and data were recorded after every 0.2 N change in load and every 0.1 mm change in deflection. Each bone was tested to fracture. Failure and fracture points were identified from the load-extension curve as the point of maximum load and where the load rapidly decreased to zero, respectively. The maximum stiffness was defined as the maximum gradient of the rising portion of this curve, and the yield point, the point at which the gradient reduced to 95% of this value. Both values were calculated from a polynomial curve fitted to the rising region of the load-extension curve in Mathcad (Mathsoft Engineering and Education Inc., Cambridge, MA, USA).
Atomic force microscopy (AFM)
A drop (5 µL) of each MV solution in Tris-buffered-saline was spotted on freshly cleaved mica substrates (Ted Pella, Redding, CA) and allowed to stand for 5 min. 
Statistical analysis
All measurements were performed at least in triplicate. Results are expressed as mean ± SEM. The data were analyzed using Student's t test. P values less than 0.05 were considered significant. For AFM, statistical differences among samples were calculated by non-parametric Mann-Whitney U analysis performed by SPSS Statistics (IBM Corporation, Armonk, NY).
RESULTS
Skeletal phenotype of [Phospho1
Immunohistochemistry demonstrated reduced P i T-1 expression in the proliferative and hypertrophic chondrocyte area of the knee joint section of the growth plate of 1-monthold P i t1 col2/col2 mice compared to WT mice (Fig. 1A) . There was visible residual P i T1 expression in these cells that was estimated to be 35% by qPCR (Fig. 1B) 3A ). Histomorphometric analyses in 15-days-old mice confirmed the osteomalacia previously reported in 10-days-old and 1-month-old Phospho1 -/-mice (Yadav et al., , 2014 (Fig. 3A, (Fig. 2A ).
There was a complete absence of mineralization in the trabecular bone in certain areas (arrows). The secondary ossification centers also show increased amount of osteoid in these mice. The vertebral sections also showed the presence of widespread hyperosteoidosis in the Phospho1 -/-mice (Fig. 3B, arrows (Fig. 6B) .
Analyses of MVs
We used atomic force microscopy (AFM) to investigate the morphology (shape and diameter) and numbers of isolated MVs. MVs appeared spherical and either individually dispersed or connected to ~1 nm-thick chains, which were interpreted as cytoskeleton macromolecules (Supplemental Fig. 1 ). Air-dried MVs were imaged without any coating or first coated with glutaraldehyde and then dried before imaging to calculate the number of filled vs unfilled MV (Supplemental Fig. 2A, B) . The distribution of the height of the vesicles was different among samples. WT MVs showed a bi-modal distribution of height values with a narrow peak centered at ~ 2.3 nm and a broad one centered at ~7.4 nm, respectively (Supplemental Fig. 2C (Fig. 7B) . The slight difference in number of MVs per µm 2 was not statistically significant. These data clearly point to a role of PHOSPHO1 in MV biogenesis. 
DISCUSSION
